The market hasn't been oversold this bad since COVID crash of 2020. Arguably market was not expecting another war and it is getting priced in. No one knows, what will be the consequences of US Iran conflict and when will the Crude price stabilize?
Similar sentiments were there in 2020, when global lockdown happened during Covid. That time it seemed most businesses would shut or report huge losses. What actually followed was longest bull run in recent times, exceeding the expectations of all and sundry.
Those who were pessimistic paid huge opportunity cost that time.
Stock price would always follow the earnings growth momentum, come want may. With at least 2 year time frame, this fall is another great opportunity to accumulate quality companies with PEG ratio of around 0.5. Many opportunities exist in this range today.
Lastly, I will not be biased this time that only small caps can generate alpha. I am not ignoring quality mid and large caps.
The GoI approved a five-year continuation of the Credit Guarantee Fund for Micro Units (CGFMU) through March 31, 2031, backed by a ₹5,000 crore corpus. Managed by the National Credit Guarantee Trustee Company Limited (NCGTC), the scheme covers collateral-free Mudra loans up to ₹20 lakh, Jan Dhan overdrafts up to ₹10,000, and Self Help Group (SHG) portfolios.
The NCGTC lists 15 NBFC-MFIs and 10 Small Finance Banks as registered Member Lending Institutions (MLIs) under the fund:
Below are the listed registered NBFC-MFIs:
▪️Satin Creditcare Network,
▪️Svatantra Microfin (IPO bound)
Registered (listed) Small Finance Banks:
▪️AU SFB
▪️Equitas SFB
▪️ESAF SFB
▪️Jana SFB
▪️Suryoday SFB
▪️Ujjivan SFB
▪️Utkarsh SFB
The Cabinet approval for continuation of the Credit Guarantee Fund for Micro Units is a major boost for India's aspiring entrepreneurs, especially our youth!
What does this mean?
Rs. 5,000 crore corpus to help facilitate over Rs 12.5 lakh crore in MUDRA loans over the next 5 years.
Credit guarantee support for collateral-free loans up to Rs. 20 lakh under PM MUDRA Yojana.
Lower guarantee fees to encourage lending to micro-enterprises.
Our aim is to empower more young Indians to turn their ideas into enterprises, create opportunities and become job creators.
https://t.co/VH823yxezC
@market_pulse_ai RBi granted in-principle authorisation to MSTC on 11 November 2026 for a trade receivables discounting network, adding a new recurring fee stream alongside sovereign auctions for commercial coal mines and state land parcels.
Indian Mining Sector is at sweetest spot ever to benefit from ongoing and upcoming manufacturing boom and commodity supercycle.
I believe MSTC is also going to big beneficiary of this theme as a government backed e-auction platform for auction of mining blocks.
Very important sector to track and keep a watch. Excellent thread.
Medical Device PLI Scheme extended by 8 years: Major push for domestic manufacturing and component localisation
The government has extended the Production Linked Incentive (PLI) scheme for medical devices until FY2035-36, with a clear shift towards manufacturing high-end medical equipment and critical components in India.
The Department of Pharmaceuticals has extended the medical devices PLI scheme by eight years.
The scheme was originally announced in Mar'20 and extended until FY35-36. Approximately Rs. 2,700 CR remains available under the existing scheme. New applicants can get up to three years to establish manufacturing facilities.
The government wants to increase domestic manufacturing of:
=> MRI machines.
=> CT scanners.
=> PET-CT scanners.
=> Ultrasound equipment.
=> High-end medical devices.
=> Critical medical electronics and components
India currently depends significantly on imports for several high-end medical equipment categories. The policy aims to reduce this dependence by developing domestic manufacturing capabilities.
Four target segments:
TS1 - Medical consumables, disposables and implants
TS2 - Critical components
TS3 - High-end medical devices that are currently at a nascent stage
TS4 - High-end medical devices that are presently only assembled in India
The revised framework introduces different incentive rates across the target segments.
TS1: 5%
TS2: 9%
TS3: 6%
TS4: 3%
The government has reduced the minimum investment requirement, including the previously cited Rs. 180 CR threshold.
Other changes include three years to establish manufacturing facilities, more flexibility in manufacturing timelines, revised incentive framework and tapering incentive rates instead of the earlier flat-rate structure.
The biggest opportunity is in reducing India's dependence on imported medical equipment while developing domestic capabilities in advanced imaging, medical electronics and precision components.
Redington posted excellent Q2 nos.
WC days is 35 days, increased by 4 Days on YoY basis
TSG grew by 91%, MSG grew by 40%, SSG grew by 39% and ESG grew 38% on YoY basis.
Debt to Equity was at 0.55x
ROCE was at 22.7% and ROE was at 21.6%
Redington India
✅ ICICI Direct initiates buy with TP of 500 in 1 year
💡Investment rationale
➤ The company has 73,000+ channel partners, ~450 brands, 168 warehouses and 71 sales offices across 40 markets through 33 in-country operations.
➤ Leadership market position and strong vendor relationship
➤ Play on premiumisation trend
➤ Diversified play with SSG and TSG emerging as key value drivers
Redington Ltd. ~ Blockbuster Q1FY27 in company's history
Shifting product mix from low margin distribution business to high margin Al services business has started to bear fruits
Revenue 34922 Cr; 35% YoY & 5% QoQ
PAT 453 Cr; 95% YoY & 58% QoQ
Such big jump might be due to jump in laptop and memory device prices.
With LTCG tax relaxation in upcoming budget, rupee appreciating and earning momentum going strong, foreign investors find India attractive after 2 years of time and price correction.
FIIs India Wapasi?
CITI India-Hike Nifty target to 28,000 from 26,000 -
Jefferies increased India’s portfolio weight by 2% to 14%
HSBC India- Upgrade India to OVERWEIGHT from Neutral
World Bank- Coal consumption+power generation by renewable goes up
S&P Global Ratings: Upgraded India's sovereign rating to 'BBB/Stable/A-2'.
Japan Credit Rating Agency (JCR): Upgraded India's Long-Term Foreign and Local Currency Issuer Ratings by one notch from 'BBB+' to 'A-' with a Stable Outlook
JPMorgan: Raised its Nifty base-case target to 30,000
Goldman Sachs: Upgraded Indian equities back to Overweight (Nifty Target-29,000)
JEFFERIES TURNS MORE BULLISH ON INDIA:
Jefferies 'Increased' India's allocation in its Asia Pacific ex-Japan portfolio to 14%, up from 12%.
That's now 2 percentage points above India's 12% weight in the —
MSCI AC Asia Pacific ex-Japan Benchmark